Role of RNA modifications in cancer

[1]  P. Sorensen,et al.  RNA modifications in brain tumorigenesis , 2020, Acta Neuropathologica Communications.

[2]  Kate D. Meyer.  DART-seq: an antibody-free method for global m6A detection , 2019, Nature Methods.

[3]  Q. Cao,et al.  N6-methyladenosine Modulates Nonsense-mediated mRNA Decay in Human Glioblastoma. , 2019, Cancer research.

[4]  Yu-Sheng Chen,et al.  Dynamic methylome of internal mRNA N7-methylguanosine and its regulatory role in translation , 2019, Cell Research.

[5]  Jun Chen,et al.  METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN , 2019, Journal of Molecular Medicine.

[6]  Chuan He,et al.  Evolution of a Reverse Transcriptase to Map N1-Methyladenosine in Human mRNA , 2019, Nature Methods.

[7]  P. van Endert.  Faculty Opinions recommendation of Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[8]  G. Hortobagyi,et al.  Current Landscape of Immunotherapy in Breast Cancer: A Review. , 2019, JAMA oncology.

[9]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[10]  W. Gilbert,et al.  mRNA structure determines modification by pseudouridine synthase 1 , 2019, Nature Chemical Biology.

[11]  Marc Graille,et al.  The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112 , 2019, Nucleic acids research.

[12]  D. O’Carroll,et al.  Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia , 2019, Cell stem cell.

[13]  A. Fatica,et al.  Interplay Between N6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer , 2019, Front. Cell Dev. Biol..

[14]  Zhike Lu,et al.  m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade , 2019, Nature Communications.

[15]  Lulu Hu,et al.  Transcriptome-wide Mapping of Internal N7-Methylguanosine Methylome in Mammalian mRNA. , 2019, Molecular cell.

[16]  Andrew J. Bannister,et al.  METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation , 2019, Molecular cell.

[17]  Chuan He,et al.  RETRACTED ARTICLE: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail , 2019, Nature Communications.

[18]  Rui Zhang,et al.  Genome-wide identification of mRNA 5-methylcytosine in mammals , 2019, Nature Structural & Molecular Biology.

[19]  A. Herbert.  ADAR and Immune Silencing in Cancer. , 2019, Trends in cancer.

[20]  Ling-Ling Chen,et al.  Cellular functions of long noncoding RNAs , 2019, Nature Cell Biology.

[21]  Hualiang Jiang,et al.  Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. , 2019, Cancer cell.

[22]  J. Wolchok,et al.  Immunotherapy of Melanoma: Facts and Hopes , 2019, Clinical Cancer Research.

[23]  Zhang Zhang,et al.  Single-base mapping of m6A by an antibody-independent method , 2019, Science Advances.

[24]  Qiangfeng Cliff Zhang,et al.  RNA structure maps across mammalian cellular compartments , 2019, Nature Structural & Molecular Biology.

[25]  R. Herbst,et al.  Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes , 2019, Clinical Cancer Research.

[26]  O. Barbash,et al.  Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer , 2019, Nature Medicine.

[27]  J. Mauer,et al.  FTO controls reversible m6Am RNA methylation during snRNA biogenesis , 2019, Nature Chemical Biology.

[28]  Li Ma,et al.  New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis , 2019, Cancers.

[29]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[30]  Chuan He,et al.  Anti-tumor immunity controlled through mRNA m6A and YTHDF1 in dendritic cells , 2019, Nature.

[31]  S. Chambers,et al.  Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. , 2019, Biochimica et Biophysica Acta. Gene Regulatory Mechanisms.

[32]  Zhike Lu,et al.  Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs , 2018, Nucleic acids research.

[33]  Jianjun Chen,et al.  IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner , 2018, Nucleic acids research.

[34]  A. Lusser,et al.  The dynamic RNA modification 5‐methylcytosine and its emerging role as an epitranscriptomic mark , 2018, Wiley interdisciplinary reviews. RNA.

[35]  Gebert Lfr,et al.  Regulation of microRNA function in animals , 2019 .

[36]  John G Doench,et al.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.

[37]  Zhike Lu,et al.  N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation , 2018, Nature Chemical Biology.

[38]  Yousheng Shu,et al.  A novel m6A reader Prrc2a controls oligodendroglial specification and myelination , 2018, Cell Research.

[39]  Chie Tomikawa.  7-Methylguanosine Modifications in Transfer RNA (tRNA) , 2018, International journal of molecular sciences.

[40]  Y. Toiyama,et al.  Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer , 2018, Journal of Translational Medicine.

[41]  Huimin Hu,et al.  ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R , 2018, Cancer cell international.

[42]  G. Mills,et al.  RNA editing derived epitopes function as cancer antigens to elicit immune responses , 2018, Nature Communications.

[43]  Y. Dor,et al.  Principles of DNA methylation and their implications for biology and medicine , 2018, The Lancet.

[44]  Chuan He,et al.  m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer , 2018, Nature Cell Biology.

[45]  Zhaoli Chen,et al.  Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. , 2018, Cancer letters.

[46]  M. Menezes,et al.  3′ RNA Uridylation in Epitranscriptomics, Gene Regulation, and Disease , 2018, Front. Mol. Biosci..

[47]  R. Hammer,et al.  Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells , 2018, Genes & development.

[48]  T. Takayama,et al.  AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer. , 2018, JCI insight.

[49]  M. Bohnsack,et al.  Modifications in small nuclear RNAs and their roles in spliceosome assembly and function , 2018, Biological chemistry.

[50]  S. Armstrong,et al.  The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia. , 2018, Blood.

[51]  Sebastian A. Leidel,et al.  Codon-specific translation reprogramming promotes resistance to targeted therapy , 2018, Nature.

[52]  L. Montanaro,et al.  Turning Uridines around: Role of rRNA Pseudouridylation in Ribosome Biogenesis and Ribosomal Function , 2018, Biomolecules.

[53]  Lai Wei,et al.  RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 , 2018, Hepatology.

[54]  Yinsheng Wang,et al.  Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA. , 2018, Analytical chemistry.

[55]  Chao Xu,et al.  YTH Domain: A Family of N6-methyladenosine (m6A) Readers , 2018, Genom. Proteom. Bioinform..

[56]  Chuan He,et al.  RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia , 2018, Nature Communications.

[57]  C. Rice,et al.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown , 2018, Cell.

[58]  Nakul M. Shah,et al.  Crosstalk between the RNA Methylation and Histone-Binding Activities of MePCE Regulates P-TEFb Activation on Chromatin. , 2018, Cell reports.

[59]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[60]  K. Somasundaram,et al.  Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance , 2018, Oncogene.

[61]  B. Ponder,et al.  ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer. , 2018, Cancer research.

[62]  James E. Bradner,et al.  R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling , 2018, Cell.

[63]  Yue Sheng,et al.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. , 2017, Cell stem cell.

[64]  E. Eisenberg,et al.  ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion , 2017, Nucleic acids research.

[65]  Chi V Dang,et al.  Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. , 2017, Trends in cell biology.

[66]  S. Jaffrey,et al.  Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1 , 2018, Nature Communications.

[67]  M. Minden,et al.  Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma , 2017, Nature Communications.

[68]  Junwei Shi,et al.  Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control , 2017, Nature.

[69]  L. Montanaro,et al.  RNA Pseudouridylation in Physiology and Medicine: For Better and for Worse , 2017, Genes.

[70]  Schraga Schwartz,et al.  The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution , 2017, Nature.

[71]  A. Hsieh,et al.  Reciprocal amplification of caspase-3 activity by nuclear export of a putative human RNA-modifying protein, PUS10 during TRAIL-induced apoptosis , 2017, Cell Death and Disease.

[72]  David R. Jones,et al.  The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK , 2017, Science Signaling.

[73]  Francine E. Garrett-Bakelman,et al.  The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.

[74]  J. Tamaru,et al.  Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer. , 2017, International journal of oncology.

[75]  Tao Pan,et al.  Dynamic RNA Modifications in Gene Expression Regulation , 2017, Cell.

[76]  X. Zuo,et al.  RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer , 2017, Proceedings of the National Academy of Sciences.

[77]  Yang Xie,et al.  The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention , 2017, Cell.

[78]  Ricardo C T Aguiar,et al.  IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation. , 2017, Cancer cell.

[79]  F. Tuorto,et al.  Statistically robust methylation calling for whole-transcriptome bisulfite sequencing reveals distinct methylation patterns for mouse RNAs , 2017, bioRxiv.

[80]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[81]  Hanzhong Wang,et al.  A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer , 2017, Oncotarget.

[82]  Chuan He,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[83]  A. Chariot,et al.  tRNA Modification: Is Cancer Having a Wobble? , 2017, Trends in cancer.

[84]  P. Pandolfi,et al.  The Epitranscriptome of Noncoding RNAs in Cancer. , 2017, Cancer discovery.

[85]  M. Menezes,et al.  The LIN28/let-7 Pathway in Cancer , 2017, Front. Genet..

[86]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[87]  Yuri Motorin,et al.  Detecting RNA modifications in the epitranscriptome: predict and validate , 2017, Nature Reviews Genetics.

[88]  Feng Liu,et al.  METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6‐methyladenosine‐dependent primary MicroRNA processing , 2017, Hepatology.

[89]  H. Qin,et al.  ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma. , 2017, International journal of oncology.

[90]  J. Liu,et al.  Star-PAP, a poly(A) polymerase, functions as a tumor suppressor in an orthotopic human breast cancer model , 2017, Cell Death & Disease.

[91]  Tsutomu Suzuki,et al.  Human BCDIN3D monomethylates cytoplasmic histidine transfer RNA , 2017, Nucleic acids research.

[92]  Olivier Elemento,et al.  Reversible methylation of m6Am in the 5′ cap controls mRNA stability , 2016, Nature.

[93]  Jie Jin,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[94]  K. Entian,et al.  Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function , 2016, RNA biology.

[95]  Chuan He,et al.  Post-transcriptional gene regulation by mRNA modifications , 2016, Nature Reviews Molecular Cell Biology.

[96]  M. Cole,et al.  MYC Mediates mRNA Cap Methylation of Canonical Wnt/β-Catenin Signaling Transcripts By Recruiting CDK7 and RNA Methyltransferase , 2016, Molecular Cancer Research.

[97]  J. Steitz,et al.  Methyltransferase-like protein 16 binds the 3′-terminal triple helix of MALAT1 long noncoding RNA , 2016, Proceedings of the National Academy of Sciences.

[98]  Nicolò Riggi,et al.  IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer , 2016, Genes & development.

[99]  R. Keith Slotkin,et al.  tRNA-derived small RNAs target transposable element transcripts , 2016, bioRxiv.

[100]  Arne Klungland,et al.  ALKBH1-Mediated tRNA Demethylation Regulates Translation , 2016, Cell.

[101]  Sebastian A. Leidel,et al.  Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer , 2016, The Journal of experimental medicine.

[102]  Samie R. Jaffrey,et al.  m6A RNA methylation promotes XIST-mediated transcriptional repression , 2016, Nature.

[103]  Ligang Wu,et al.  YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.

[104]  Maurizio Pellecchia,et al.  ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. , 2016, Cell stem cell.

[105]  Ping Wang,et al.  Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. , 2016, Molecular cell.

[106]  Blerta Xhemalçe,et al.  Who Watches the Watchmen: Roles of RNA Modifications in the RNA Interference Pathway , 2016, PLoS genetics.

[107]  Kaori Takai,et al.  RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. , 2016, Cancer letters.

[108]  G. B. Robb,et al.  mRNA capping: biological functions and applications , 2016, Nucleic acids research.

[109]  R. Gregory,et al.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. , 2016, Molecular cell.

[110]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[111]  M. Schapira.  Structural Chemistry of Human RNA Methyltransferases. , 2016, ACS chemical biology.

[112]  Gideon Rechavi,et al.  The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA , 2016, Nature.

[113]  P. Limbach,et al.  Mass spectrometry of modified RNAs: recent developments. , 2016, The Analyst.

[114]  K. Nishikura,et al.  A-to-I editing of coding and non-coding RNAs by ADARs , 2015, Nature Reviews Molecular Cell Biology.

[115]  Thomas J. Begley,et al.  Trm9-Catalyzed tRNA Modifications Regulate Global Protein Expression by Codon-Biased Translation , 2015, PLoS genetics.

[116]  L. Nguyen,et al.  Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine , 2015, The Journal of experimental medicine.

[117]  Saeed Tavazoie,et al.  HNRNPA2B1 Is a Mediator of m6A-Dependent Nuclear RNA Processing Events , 2015, Cell.

[118]  Shiqing Ma,et al.  Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. , 2015, Nature chemical biology.

[119]  L. Crinò,et al.  Dyskerin and TERC expression may condition survival in lung cancer patients , 2015, Oncotarget.

[120]  R. Gregory,et al.  Identification of small molecule inhibitors of Zcchc11 TUTase activity , 2015, RNA biology.

[121]  Sebastian A. Leidel,et al.  Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity , 2015, Cell.

[122]  Christopher E. Mason,et al.  Single-nucleotide resolution mapping of m6A and m6Am throughout the transcriptome , 2015, Nature Methods.

[123]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[124]  Hiroki Ueda,et al.  Transcriptome-wide identification of adenosine-to-inosine editing using the ICE-seq method , 2015, Nature Protocols.

[125]  S. Tavazoie,et al.  N6-methyladenosine marks primary microRNAs for processing , 2015, Nature.

[126]  Li Wang,et al.  Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data , 2015, Nucleic acids research.

[127]  M. Bohnsack,et al.  WBSCR22/Merm1 is required for late nuclear pre-ribosomal RNA processing and mediates N7-methylation of G1639 in human 18S rRNA , 2015, RNA.

[128]  Albert Kriegner,et al.  Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan , 2015, Nature Communications.

[129]  Steven J. M. Jones,et al.  Hypo Adenosine-to-Inosine miR-455-5p Editing Promotes Melanoma Growth and Metastasis , 2015, Nature Cell Biology.

[130]  E. Eisenberg,et al.  Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma , 2015, Genome Biology.

[131]  D. Patel,et al.  Uridylation by TUT4 and TUT7 Marks mRNA for Degradation , 2014, Cell.

[132]  C. James,et al.  Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma , 2014, Nature Medicine.

[133]  Sheng Li,et al.  The pivotal regulatory landscape of RNA modifications. , 2014, Annual review of genomics and human genetics.

[134]  M. Tatsuka,et al.  tRNA Modifying Enzymes, NSUN2 and METTL1, Determine Sensitivity to 5-Fluorouracil in HeLa Cells , 2014, PLoS Genetics.

[135]  Maxwell R. Mumbach,et al.  Transcriptome-wide Mapping Reveals Widespread Dynamic-Regulated Pseudouridylation of ncRNA and mRNA , 2014, Cell.

[136]  W. Gilbert,et al.  Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells , 2014, Nature.

[137]  Y. Lou,et al.  Nucleotidyl transferase TUT1 inhibits lipogenesis in osteosarcoma cells through regulation of microRNA-24 and microRNA-29a , 2014, Tumor Biology.

[138]  K. Tsujikawa,et al.  Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. , 2014, Bioorganic & medicinal chemistry letters.

[139]  G. Pupo,et al.  BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact , 2014, Clinical Cancer Research.

[140]  Miao Yu,et al.  A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.

[141]  Shi-ting Li,et al.  Characterizing the Role of PCDH9 in the Regulation of Glioma Cell Apoptosis and Invasion , 2014, Journal of Molecular Neuroscience.

[142]  Nian Liu,et al.  Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA , 2013, RNA.

[143]  Š. Vaňáčová,et al.  Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs , 2013, RNA.

[144]  Jernej Ule,et al.  NSun2-Mediated Cytosine-5 Methylation of Vault Noncoding RNA Determines Its Processing into Regulatory Small RNAs , 2013, Cell reports.

[145]  Zhiming Zhang,et al.  The Wnt–&bgr;-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion , 2013, Journal of Cell Science.

[146]  S. Peña-Llopis,et al.  A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth , 2013, Nature Communications.

[147]  Schraga Schwartz,et al.  Transcriptome-Wide Mapping of 5-methylcytidine RNA Modifications in Bacteria, Archaea, and Yeast Reveals m5C within Archaeal mRNAs , 2013, PLoS genetics.

[148]  R. Gregory,et al.  A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway , 2013, Nature.

[149]  Marko Hočevar,et al.  A variant in FTO shows association with melanoma risk not due to BMI , 2013, Nature Genetics.

[150]  Arne Klungland,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[151]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[152]  R. Boldrini,et al.  ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis , 2012, Oncogene.

[153]  J. Waldron,et al.  Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway , 2012, Oncotarget.

[154]  Hyeshik Chang,et al.  Mono-Uridylation of Pre-MicroRNA as a Key Step in the Biogenesis of Group II let-7 MicroRNAs , 2012, Cell.

[155]  S. Robson,et al.  Human RNA Methyltransferase BCDIN3D Regulates MicroRNA Processing , 2012, Cell.

[156]  R. Gregory,et al.  Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). , 2012, RNA.

[157]  Chuan He,et al.  Mapping new nucleotide variants in the genome and transcriptome , 2012, Nature Biotechnology.

[158]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[159]  T. Preiss,et al.  Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA , 2012, Nucleic acids research.

[160]  J. Opitz,et al.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility , 2012, Nature Genetics.

[161]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[162]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[163]  Tao Pan,et al.  Genome-wide analysis of N1-methyl-adenosine modification in human tRNAs. , 2010, RNA.

[164]  L. Montanaro,et al.  Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. , 2010, Cancer research.

[165]  Omar Abdel-Wahab,et al.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.

[166]  R Engers,et al.  DKC1 overexpression associated with prostate cancer progression , 2009, British Journal of Cancer.

[167]  E. Wahle,et al.  Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. , 2008, RNA.

[168]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[169]  A. Ehrenhofer-Murray,et al.  Hypermethylation of yeast telomerase RNA by the snRNA and snoRNA methyltransferase Tgs1 , 2008, Journal of Cell Science.

[170]  Hans Ronne,et al.  Evidence that tRNA modifying enzymes are important in vivo targets for 5-fluorouracil in yeast. , 2008, RNA.

[171]  Jay Belsky,et al.  For Better and For Worse , 2007 .

[172]  Georges Martin,et al.  RNA-specific ribonucleotidyl transferases. , 2007, RNA.

[173]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[174]  Christiane Branlant,et al.  Identification of modified residues in RNAs by reverse transcription-based methods. , 2007, Methods in enzymology.

[175]  F. Watt,et al.  The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.

[176]  G. Collins.  The next generation. , 2006, Scientific American.

[177]  R. Holcombe,et al.  Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. , 2005, International journal of oncology.

[178]  Mitsutoshi Nakamura,et al.  High Expression of a New Marker PCA-1 in Human Prostate Carcinoma , 2005, Clinical Cancer Research.

[179]  P. Cohen,et al.  The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells , 2005, The EMBO journal.

[180]  T. Shiomi,et al.  Tumorigenesis and Neoplastic Progression ADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor , 2004 .

[181]  S. L. Davis,et al.  Regulation of nuclear receptor activity by a pseudouridine synthase through posttranscriptional modification of steroid receptor RNA activator. , 2004, Molecular cell.

[182]  P. Athanassiadou,et al.  Expression of p120, Ki‐67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value , 2004, Cytopathology : official journal of the British Society for Clinical Cytology.

[183]  P. Beal,et al.  Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design. , 2003, Journal of the American Chemical Society.

[184]  Francesco Piazza,et al.  Dyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification , 2003, Science.

[185]  P. Bates,et al.  Reversal of DNA alkylation damage by two human dioxygenases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[186]  E. Phizicky,et al.  Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. , 2002, RNA.

[187]  Jiunn-Liang Chen,et al.  A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. , 2002, Nucleic acids research.

[188]  T. Kondo,et al.  Expression of nucleolar protein p120 predicts poor prognosis in patients with stage I lung adenocarcinoma. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[189]  K. Mizumoto,et al.  Cloning and characterization of three human cDNAs encoding mRNA (guanine-7-)-methyltransferase, an mRNA cap methylase. , 1998, Biochemical and biophysical research communications.

[190]  S. Klauck,et al.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions , 1998, Nature Genetics.

[191]  G. Keith,et al.  Mobilities of modified ribonucleotides on two-dimensional cellulose thin-layer chromatography. , 1995, Biochimie.

[192]  Ravinder Singh,et al.  Gamma-monomethyl phosphate: a cap structure in spliceosomal U6 small nuclear RNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[193]  Brenda L. Bass,et al.  An unwinding activity that covalently modifies its double-stranded RNA substrate , 1988, Cell.

[194]  B. Maden.  Locations of methyl groups in 28 S rRNA of Xenopus laevis and man. Clustering in the conserved core of molecule. , 1988, Journal of molecular biology.

[195]  J. Freeman,et al.  Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase. , 1988, Cancer research.

[196]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[197]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.

[198]  D. Melton,et al.  Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity , 1987, Cell.

[199]  Brenda L. Bass,et al.  A developmentally regulated activity that unwinds RNA duplexes , 1987, Cell.

[200]  B. Maden.  Identification of the locations of the methyl groups in 18 S ribosomal RNA from Xenopus laevis and man. , 1986, Journal of molecular biology.

[201]  R T Borchardt,et al.  Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication. , 1978, The Journal of biological chemistry.

[202]  R. Desrosiers,et al.  Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[203]  R. Perry,et al.  Existence of Methylated Messenger RNA in Mouse L Cells , 1974 .

[204]  R. C. Macridis.  A review , 1963 .

[205]  F. Davis,et al.  Ribonucleic acids from yeast which contain a fifth nucleotide. , 1957, The Journal of biological chemistry.